The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

8.41%Dividend Yield

Mar 26

$0.09

Dec 25

$0.23

Sep 25

$0.26

Jul 25

$0.37

Apr 25

$0.55

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

-45.85%

1Y Growth

-32.81%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LABD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Direxion Daily S&P Biotech Bull 3X

LABU

Mkt Cap0

Direxion Daily S&P Biotech Bull 3X Shares, the bullish counterpart to LABD, offering 3x leveraged exposure to the same index but for those betting on the index's rise.

ProShares UltraShort Nasdaq Biotechnology -2x Shares

BIS

Mkt Cap0

ProShares UltraShort Nasdaq Biotechnology, offers 2x daily short leverage to the NASDAQ Biotechnology Index, competing directly with LABD's inverse biotech focus.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF, provides exposure to the biotech industry, competing with LABD by targeting the same sector without leverage.

iShares Biotechnology

IBB

Mkt Cap0

iShares Biotechnology ETF, tracks the same biotech sector as LABD, offering an alternative for investors looking to invest in biotech without leverage.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF, competes by offering exposure to the biotech sector, similar to LABD but without the leveraged inverse strategy.

ALPS Medical Breakthroughs

SBIO

Mkt Cap0

ALPS Medical Breakthroughs ETF, targets the biotech and healthcare sectors, providing an alternative investment in the same industry as LABD.

ProShares Ultra Nasdaq Biotechnology 2X Shares

BIB

Mkt Cap0

ProShares Ultra Nasdaq Biotechnology, offers 2x daily leverage to the NASDAQ Biotechnology Index, competing with LABD by targeting the same sector with a bullish perspective.

Zenas Biopharma

ZBIO

Mkt Cap1.21B

ProShares UltraPro Short NASDAQ Biotechnology, provides 3x daily inverse leverage to the NASDAQ Biotechnology Index, directly competing with LABD's 3x inverse strategy.

Virtus Biotech

BBP

Mkt Cap0

Virtus LifeSci Biotech Products ETF, competes by investing in biotech product companies, offering a different angle on the same sector as LABD.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund, competes by providing exposure to biotech firms, similar to LABD's focus but without the leveraged inverse strategy.

Holdings

About

The Direxion Daily S&P Biotech Bull and Bear 3X ETFs seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.

CEO

Country

United States

ISIN

US25461H8530

Listings

0 Comments

Share your thoughts

FAQ

What is Direxion Daily S&P Biotech Bear 3X stock price today?▼

The current price of LABD is $13.94 USD — it has decreased by -0.78% in the past 24 hours. Watch Direxion Daily S&P Biotech Bear 3X stock price performance more closely on the chart.

What is Direxion Daily S&P Biotech Bear 3X stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Direxion Daily S&P Biotech Bear 3X stocks are traded under the ticker LABD.

Is Direxion Daily S&P Biotech Bear 3X stock price growing?▼

LABD stock has fallen by -10.81% compared to the previous week, the month change is a -12.22% fall, over the last year Direxion Daily S&P Biotech Bear 3X has showed a -85.42% decrease.

Does Direxion Daily S&P Biotech Bear 3X pay dividends?▼

Yes, LABD dividends are paid quarterly. The last dividend per share was 0.09 USD. As of today, Dividend Yield (FWD)% is 8.41%.

In which sector is Direxion Daily S&P Biotech Bear 3X located?▼

Direxion Daily S&P Biotech Bear 3X operates in the Other sector.

When did Direxion Daily S&P Biotech Bear 3X complete a stock split?▼

The last stock split for Direxion Daily S&P Biotech Bear 3X was on September 29, 2025 with a ratio of 1:10.